Journal of the American Society of Nephrology

Founded in 1966, the American Society of Nephrology (ASN) is the world’s largest professional society devoted to the study of kidney disease. Composed of 11,000 physicians and scientists, ASN promotes expert patient care, advances medical research, and educates the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. Each year, ASN provides nearly 500 research and travel grants. ASN annual meetings are attended by 14,000 physicians and researchers, and regional meetings are held throughout the year. The society publishes the Journal of the American Society of Nephrology (JASN) (impact factor 7.111), the Clinical Journal of the American Society of Nephrology, the Nephrology Self-Assessment Program (NephSAP), ASN Kidney News, and Kidney Daily. JASN, established in 1990, publishes original articles of the highest quality that are relevant to the broad field of nephrology. CJASN, whose inaugural issue was in January 2006, is a journal dedicated to advancing the practice of renal medicine by reporting novel and rigorous clinical research.

Publisher
American Society of Nephrology
Website
http://www.asn-online.org/
Impact factor
7.111 ()

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Analysis forecasts effects of new race-free kidney-function testing

Race—a social construct—is highly unreliable as a predictor of biologic variation across populations. Mounting evidence showing that race is not biology has called into question the use of many diagnostic tests and treatment ...

Medications

Real-world data links rosuvastatin to adverse effects on kidneys

Rosuvastatin is associated with increased risks for hematuria, proteinuria, and kidney failure with replacement therapy (KFRT) compared with atorvastatin use, according to a study published online July 19 in the Journal of ...

Medications

Real-world data links rosuvastatin with signs of kidney damage

Statins can effectively lower high cholesterol, and many individuals take rosuvastatin, one member of this drug class. New research based on patient health records and published in Journal of the American Society of Nephrology ...

Diseases, Conditions, Syndromes

Study reveals risk of death after hurricanes for people on dialysis

Many individuals with kidney failure rely on dialysis, but access to this life-sustaining therapy can be impeded by extreme weather events—such as hurricanes—that disrupt power, water, and transportation systems. A recent ...

page 1 from 36